Bruker Corporation announced its financial results for the second quarter ended June 30, 2025, on August 4, 2025. The company reported revenues of $797.4 million, a decrease of 0.4% compared to $800.7 million in the second quarter of 2024.
Organic revenue declined by 7.0% year-over-year, with constant-exchange rate (CER) revenue decreasing by 3.3%. Non-GAAP operating income was $72.0 million, down from $110.7 million in Q2 2024, resulting in a non-GAAP operating margin of 9.0%, a decrease of 480 basis points.
Non-GAAP diluted earnings per share (EPS) were $0.32, a decrease of 38.5% compared to $0.52 in the prior year. Bruker lowered its full-year 2025 guidance, now expecting revenues of $3.43 billion to $3.50 billion and non-GAAP EPS between $1.95 and $2.05. The company also announced an expanded cost management initiative targeting $100 million to $120 million in annualized reductions for fiscal year 2026.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.